Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06289335
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2024-02-26
Brief Title:
Dexmedetomidine Compared to Ondansetron for Postanaesthetic Shivering in Patients Undergoing a Cesarean Section
Sponsor:
Hospital Central Dr Ignacio Morones Prieto
Organization:
Hospital Central Dr Ignacio Morones Prieto
Study Overview
Official Title:
Dexmedetomidine Compared With Ondansetron in Treating Postanesthetic Shivering in Patients After Regional Anesthesia for Cesarean Section-a Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate the efficiency of management with intravenous dexmedetomidine compared to intravenous ondansetron to achieve the disappearance of post-anesthetic shivering in a shorter time in the obstetric patient undergoing cesarean section under regional anesthesia
Detailed Description:
Randomized clinical trial with 40 pregnant patients between 18 and 45 years old with ASA American Society of Anesthesiologist II or III undergoing scheduled or emergency cesarean section with regional anesthesia and who presented grade tremor 1 based on the BSAS Bedside shivering assessment scale scale at the Hospital Central from San Luis Potosi Mexico The main objective of this study was to quantify the time that elapsed from the end of the administration of the medication until the disappearance of the tremor which was measured in minutes The evaluation of the disappearance persistence or reappearance of the tremor was solely visual by the anesthesiology staff
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None